Francois Haddad, MD
Basic profileAdvanced Heart Failure and Transplant Cardiology
Francois Haddad is a Cardiology physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 20 Apr 2024.
Clinical trials
- Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS)
Sponsor: Francois Haddad
- Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
Sponsor: University Medical Centre Ljubljana
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Actelion Pharmaceuticals US, Inc.Program year20252 payments
- Merck Sharp & Dohme LLCProgram year202416 payments$14,564openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202310 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.6%Statin18.9%Rosuvastatin Calcium46%Atorvastatin Calcium30%Pravastatin Sodium17%Simvastatin7%Part D<11 patientsBeta blocker16%Carvedilol42%Metoprolol Succinate35%Metoprolol Tartrate15%Bisoprolol Fumarate8%Part D<11 patients+ 10 more classes in this area
Blood & clotting
8.7%Factor Xa inhibitor6.7%Eliquis74%Xarelto26%Part D<11 patientsP2Y12 inhibitor2.1%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
7.9%SGLT2 inhibitor3.9%Jardiance100%Part D≥16 patientsProton pump inhibitor1.2%Pantoprazole Sodium100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2022 per NIH RePORTER. The latest:
- Scientific Human Biomarker Exposure Monitoring Core (HEMC) for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
Stanford University
FY2022$225,751P01HL152953 - Scientific Human Biomarker Exposure Monitoring Core (HEMC) for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
Stanford University
FY2021$225,787P01HL152953
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”